Growth Metrics

Odyssey Health (ODYY) FCF Margin (2014 - 2016)

Odyssey Health's quarterly FCF Margin came in at 63.13% in Q3 2016, up 31.13% quarter-over-quarter from 91.66% in Q2 2016.

Odyssey Health has reported FCF Margin for 3 years, with the latest figure at 63.13% in Q3 2016.

  • For the quarter ending Q3 2016, FCF Margin changed N/A year-over-year to 63.13%; the trailing twelve-month figure through Apr 2017 stood at 594.98% (down 36233.0% YoY), and the FY2016 full-year result was 171.34%, down 24358.0% from the prior year.
  • FCF Margin for Q3 2016 stood at 63.13%, up from 91.66% in the prior quarter.
  • The five-year high for FCF Margin was 87.73% in Q4 2014, with the low at 91.66% in Q2 2016.
  • Average FCF Margin over 3 years is 3.95%, with a median of 26.77% recorded in 2015.
  • Peak annual rise in FCF Margin reached 11843 bps in 2016, while the deepest fall reached 11843 bps in 2016.
  • Tracing ODYY's FCF Margin over 3 years: stood at 87.73% in 2014, then sank by 69 bps to 26.77% in 2015, then sank by 336 bps to 63.13% in 2016.
  • The last three FCF Margin figures came in at 63.13% (Q3 2016), 91.66% (Q2 2016), and 26.77% (Q2 2015), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 8.20%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 6.89%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 25.51%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 3.29%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -1.28%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 6.68%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 37.67%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 3.98%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 15.44%
10 Odyssey Health - - - -

Historic Data

Download Data 🔒
DateValue
Jul 31, 2016 -63.13%
Apr 30, 2016 -91.66%
Apr 30, 2015 26.77%
Jan 31, 2015 60.06%
Oct 31, 2014 87.73%